Flex Pharma (FLKS) PT Lowered to $9 at Jefferies Following 4Q
Tweet Send to a Friend
Jefferies lowered its price target on Flex Pharma (NASDAQ: FLKS) to $9.00 (from $11.00) while maintaining a Buy rating. FLKS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
